Download | < Back |
16 Feb 2017 | |
Biocon Ltd has informed BSE regarding a Press Release dated February 16, 2017, titled "U.S. FDA Accepts Biologies License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review". | |
View all announcements for BIOCON LTD. | Source: BSE India |